
FDA Schedules Public Hearing on Therapeutic Use of Psychedelic Drugs
FDA sets a September 14 public hearing on therapeutic psychedelics and finalizes its first clinical trial guidance for psilocybin, LSD and MDMA.
Evidence-based articles, treatment guides, and the latest news in addiction recovery and mental health.

FDA sets a September 14 public hearing on therapeutic psychedelics and finalizes its first clinical trial guidance for psilocybin, LSD and MDMA.

New Mexico reports 900 overdose deaths in 2025, a 21% increase while national fatalities drop 14%. Fentanyl drives crisis in Rio Arriba, Santa Fe, and Taos counties with 65%+ spikes.

Veterinary sedative medetomidine, 100-200 times more potent than xylazine, is appearing in Minnesota's illicit fentanyl supply, creating naloxone-resistant overdoses and severe withdrawal symptoms.

SAMHSA bans federal funding for clean needles and syringe services while cutting agency staff by half, alarming addiction treatment providers.

Washington Attorney General opens trial against Albertsons, alleging pharmacy chain failed to prevent opioid misuse while prioritizing prescription volume over patient safety.

Delaware Opioid Settlement Commission launches fourth competitive grant round with $12.75 million available for prevention, treatment, harm reduction, and recovery support programs.

Manatee County, Florida reports dramatic 56% decline in opioid overdose deaths through coordinated naloxone distribution, expanded treatment access, and peer recovery support programs.

Wisconsin Watch investigation reveals $160 million in opioid settlement funds received by local governments, with 16 municipalities yet to spend any allocations.

Governor Kay Ivey awards $70,694 grant to implement substance abuse treatment combining medication-assisted treatment with counseling for inmates at Jefferson County Jail.